HOX proteins and leukemia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

1. Genetic and phenotypic continuum of HOXA genes: A case with double HOXA9/HOXA13 mutations.Molecular medicine reports · 2023
   Article
2. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.Lipids in health and disease · 2022
   Article
3. The Historical Relationship Between Meis1 and Leukemia.Advances in experimental medicine and biology · 2022
   Review
4. Histone H3K36me2-Specific Methyltransferase ASH1L Promotes MLL-AF9-Induced Leukemogenesis.Frontiers in oncology · 2021
   Article
5. Optimization of Ligands Using Focused DNA-Encoded Libraries To Develop a Selective, Cell-Permeable CBX8 Chromodomain Inhibitor.ACS chemical biology · 2020
   Article
6. Oncogenic and tumor suppressor function of MEIS and associated factors.Turkish journal of biology = Turk biyoloji dergisi · 2020
   Article
7. Activity-Dependent Regulation of the Proapoptotic BH3-Only GeneG3 (Bethesda, Md.) · 2019
   Article
8. Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion.Pathology oncology research : POR · 2018
   Article
9. MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9.Oncotarget · 2017
   Article
10. Taking a Bad Turn: Compromised DNA Damage Response in Leukemia.Cells · 2017
    Review
11. Correlation Between Meis1 and Msi1 in Esophageal Squamous Cell Carcinoma.Journal of gastrointestinal cancer · 2016
    Article
12. Deregulation of the HOXA9/MEIS1 axis in acute leukemia.Current opinion in hematology · 2016
    Review
13. To Be Specific or Not: The Critical Relationship Between Hox And TALE Proteins.Trends in genetics : TIG · 2016
    Review
14. Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets.Oncogene · 2016
    Review
15. Transcriptome Profiling of Pediatric Core Binding Factor AML.PloS one · 2015
    Article
16. C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
17. PBX3 is an important cofactor of HOXA9 in leukemogenesis.Blood · 2013
    Article
18. Implication of IRF4 aberrant gene expression in the acute leukemias of childhood.PloS one · 2013
    Article
19. HLX in AML: novel prognostic and therapeutic target.Oncotarget · 2012
    Article
20. Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia.Blood cells, molecules & diseases · 2012
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as